SCHEMBL12759649

SCHEMBL12759649

Cc1ccc2c(c1)c1ccccc1c1ncc(-c3c(C)c(C)c(C)c(C)c3C)n21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
NR1I2 O75469 1/20 0.39
AHR P35869 1/20 0.39
KMT2A Q03164 1/20 0.39
PGR P06401 1/20 0.39
RORA P35398 1/20 0.39
RORC P51449 1/20 0.39
RORB Q92753 1/20 0.39
FGFR1 P11362 1/20 0.35
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34
IDO1 P14902 2/20 0.33
PTGDR2 Q9Y5Y4 2/20 0.32
PLK1 P53350 1/20 0.31
KDM4E B2RXH2 3/20 0.31
HTT P42858 3/20 0.31
MAPT P10636 2/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL841646 0.88 PGR (0.38) MEN1NR1I2AHRKMT2APGR
SCHEMBL12759654 0.88 PGR (0.38) MEN1NR1I2AHRKMT2APGR
SCHEMBL29631725 0.88 PGR (0.38) MEN1NR1I2AHRKMT2APGR
SCHEMBL29801927 0.87 PGR (0.37) MEN1NR1I2AHRKMT2APGR
SCHEMBL29911566 0.87 PGR (0.37) MEN1NR1I2AHRKMT2APGR
SCHEMBL861977 0.84 PGR (0.35) MEN1NR1I2AHRKMT2APGR
SCHEMBL840348 0.84 PGR (0.35) MEN1NR1I2AHRKMT2APGR
SCHEMBL861219 0.82 RORA (0.34) MEN1NR1I2AHRKMT2APGR
SCHEMBL861600 0.81 PGR (0.33) MEN1NR1I2AHRKMT2APGR
SCHEMBL21917733 0.79 PTGER4 (0.34) MEN1NR1I2AHRKMT2APGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150311455-A1 Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device UDC IRELAND LTD (IE) 2015-10-29 US disclosed
US-20150311455-A1 Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device UDC IRELAND LTD (IE) 2015-10-29 US disclosed
US-9062084-B2 Method of forming metal complex compound, and organic electroluminescence device UDC Ireland (IE) 2015-06-23 US disclosed
US-9062084-B2 Method of forming metal complex compound, and organic electroluminescence device UDC Ireland (IE) 2015-06-23 US disclosed
US-20110050093-A1 METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2011-03-03 US disclosed
US-20110050093-A1 METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110050093-A1 METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE ZFR, PORCN, OR10J3 MEN1 359/4885NR1I2 3484/4885AHR 2988/4885
US-20150311455-A1 Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device ZFR, PORCN, OR10J3 MEN1 359/4885NR1I2 3484/4885AHR 2988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.